CGBIO Targets European Aesthetic Market… Unveils Suture ‘LUXX’ and ‘EGF Skin Booster’ for the First Time Launches PDO suture ‘LUXX’ in the global market… Possesses diverse lines with differentiated technology Unveils the world’s first next-generation skin booster containing… 2024-04-08 cgbio
CGBio discovers a breakthrough in “cartilage” regeneration… Demonstrates the regenerative capabilities of “Hyaluronic Acid Gel” for cartilage Hyaluronic acid gel, notable for its high adhesiveness, effectively releases the growth factor (TGF-β3), promoting cartilage regeneration Featured in the prestigious international… 2024-03-25 cgbio
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market The first Korean developed medical device for spine implantation Expecte to receive faster approval in the U.S. by priority support from the… 2024-01-03 cgbio
Bali’s First K-Aesthetic Live Demonstration Showcased at “Beyond Aesthetic – Meet the Masters” Introduced cosmetic surgery solutions to 100 medical professionals from the US, Europe, and other regions worldwide Presented K-Beauty procedures and imparted knowledge… 2023-11-07 cgbio
CGBio signs a 100 million USD license out agreement for calcium filler FACETEM… Taking on the challenge of acquiring the “first” permit for calcium filler in China Signing a license out agreement with HTDK, a large Chinese medical distributor… Achieving sales of 100 million USD for the first five… 2023-10-23 cgbio
CGBio’s Calcium Filler ‘FACETEM’ Launched in Indonesia, Expanding its Full Filler Product Line Following the release of Giselleligne and Aileene in 2021, CGBio’s complete filler lineup enters the market. Boosting global presence based on the… 2023-09-21 cgbio
CGBio Completes Global Seminar ‘Meet the Master’ in 3 Indonesian Cities… “Introducing Effective Utilization of Bone Substitutes” Conducted consecutively in major Indonesian cities, notably Jakarta, Surabaya, and Bali Shares insights on the latest trends in bone substitute applications and… 2023-08-28 cgbio
CGBio applies for a permit for its HA filler GISELLELIGNE in the Middle East countries… making the first advance for its premium line into the Middle Eastern markets If the permit is granted, it would represent a significant achievement, marking the successful introduction of all the company’s filler lines for… 2023-08-21 cgbio
CGBio obtains FDA clearance for spine implant Advanced LumFix… Blueprint for entry into the US spine market Determined to accelerate the entry into the US market through American subsidiary CGMedTech LumFix that provides a set of implant materials and… 2023-08-16 cgbio
CGBio’s HA filler Aileene becomes the first domestic filler to obtain a permit from Australia… Gaining a foothold in the Oceania market Acquisition of the first permit from Australia among domestic fillers, the achievement from concentrating all expertise in overseas licensing Plans to commence… 2023-07-26 cgbio
